We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Industry Pages is released annually by OCT Clinical, a leading CRO in Eastern Europe, and gives accurate and useful information on the clinical trials environment in Eastern Europe, and how these clinical trials have performed in each respective year. The report is issued for industry experts, who are looking for new options to conduct clinical trials and examining the ecosystem of Eastern Europe.
Eastern Europe remains one of the top destinations for clinical trials globally. High recruitment rates, competitive quotes and a solid regulatory framework make the region a great option for companies seeking to optimize their clinical trials without compromising quality, and to avoid issues common to other regions.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
